The shares of this microcap company gained up to 2.4 percent after the company received two significant letters of intent from National Fertilizers Limited worth Rs 4.31 crore
Aristo Bio-Tech and Lifescience Ltd has a market capitalization of Rs 72.84 crore, the shares were trading at Rs 107.00 per share, increasing around 1 percent as compared to the previous closing price of Rs 106.15 apiece.
Reason for rise:-
Today, the shares of the company have seen a positive movement after Aristo Bio-Tech and Lifescience Ltd received two significant letters of intent from National Fertilizers Limited for supplying various agrochemicals worth Rs 4.31 crore.
Financial performance:-
The company’s revenue soared 16%, dipped from ₹133 crore in H2FY24 to ₹112 crore in H1FY24, while net profit plummeted by 13%, growing from ₹3 crore to ₹1 crore during the same period, reflecting strong financial performance and continued business growth.
Geographically footprint:-
The company supplies agrochemical products across 20 Indian states, including Assam, Maharashtra, and Tamil Nadu, and exports to 15 countries such as Australia, Germany, and South Africa, focusing on enhancing crop protection through high-quality agrochemical solutions.
Ratio analysis & Shareholding Pattern:-
In terms of major financial measures, the firm recorded a return on equity (RoE) of 11.59 percent and a return on capital employed (RoCE) of 16.24 percent for the fiscal year 23-24. Furthermore, the net profit margin was 1.58 percent throughout the same time.
According to the most recent shareholding pattern, the Promoters control 73.37 percent of the shares, while Foreign Institutional Investors own 0 percent. Retail investors hold the remaining 26.63 percent of the shares.
Company profile:-
Aristo Bio-Tech and Lifescience Limited manufactures, formulates, supplies, and packages numerous pesticides, including insecticides, herbicides, fungicides, plant growth regulators, and a wide range of other agrochemicals, both in India and for export.
Written by:- Abhishek Singh
Disclaimer
The views and investment tips expressed by investment experts/broking houses/rating agencies on tradebrains.in are their own, and not that of the website or its management. Investing in equities poses a risk of financial losses. Investors must therefore exercise due caution while investing or trading in stocks. Dailyraven Technologies or the author are not liable for any losses caused as a result of the decision based on this article. Please consult your investment advisor before investing.
